fidarestat has been researched along with Cataract, Membranous in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alaparthi, MD; Bandaru, S; Chittineni, PR; Gopinath, G; Krupadanam, GLD; Pasala, VK; Perugu, S; Sagurthi, SR; Sankeshi, V | 1 |
| Ciddi, V; Dodda, D | 1 |
| Ighani-Hosseinabad, F; Ramana, KV; Srivastava, SK; van Kuijk, FJ; Yadav, UC | 1 |
| Akagi, Y; Kubo, E; Takamura, Y; Tsuzuki, S | 1 |
| Akagi, Y; Kubo, E; Morikubo, S; Takamura, Y; Tsuzuki, S | 1 |
| Ali, TK; Drel, VR; El-Remessy, AB; Julius, U; Obrosova, IG; Pacher, P; Shin, J | 1 |
| Akagi, Y; Fukuda, M; Kubo, E; Miyoshi, N | 1 |
7 other study(ies) available for fidarestat and Cataract, Membranous
| Article | Year |
|---|---|
Design and synthesis of chiral 2H-chromene-N-imidazolo-amino acid conjugates as aldose reductase inhibitors.
Topics: Aldehyde Reductase; Amino Acids; Animals; Benzopyrans; Blood Glucose; Catalytic Domain; Cataract; Diabetes Complications; Disease Models, Animal; Drug Design; Enzyme Activation; Enzyme Inhibitors; Imidazoles; Inhibitory Concentration 50; Molecular Docking Simulation; Rats; Stereoisomerism; Structure-Activity Relationship | 2016 |
Therapeutic potential of resveratrol in diabetic complications: In vitro and in vivo studies.
Topics: Aldehyde Reductase; Animals; Cataract; Cattle; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Imidazolidines; Inhibitory Concentration 50; Kidney Function Tests; Lens, Crystalline; Male; Rats; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin | 2014 |
Prevention of posterior capsular opacification through aldose reductase inhibition.
Topics: Actins; Aldehyde Reductase; Animals; beta-Crystallins; Blotting, Western; Capsulorhexis; Cataract; Cell Count; Cell Differentiation; Cell Proliferation; Cells, Cultured; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Epithelial Cells; Fibroblast Growth Factor 2; Imidazolidines; Immunoenzyme Techniques; Intercellular Adhesion Molecule-1; Lens Capsule, Crystalline; Microscopy, Fluorescence; NF-kappa B; Organ Culture Techniques; Proliferating Cell Nuclear Antigen; Signal Transduction; Swine | 2009 |
Apoptotic cell death in the lens epithelium of rat sugar cataract.
Topics: Aldehyde Reductase; Animals; Apoptosis; Blotting, Western; Cataract; DNA Fragmentation; Epithelial Cells; Galactitol; Galactose; Genes, p53; Imidazoles; Imidazolidines; In Situ Nick-End Labeling; Lens, Crystalline; Male; Models, Animal; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Tumor Suppressor Protein p53 | 2003 |
[The inhibitory effect of aldose reductase inhibitor for proliferation in the lens epithelial cells of rat sugar cataract].
Topics: Aldehyde Reductase; Animals; Cataract; Cell Division; Epithelial Cells; Galactose; Imidazoles; Imidazolidines; Lens, Crystalline; Male; Rats; Rats, Sprague-Dawley; Sugar Alcohols | 2003 |
Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.
Topics: Aldehyde Reductase; Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Blood Glucose; Blotting, Western; Cataract; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glial Fibrillary Acidic Protein; Imidazolidines; Immunohistochemistry; In Situ Nick-End Labeling; Neuroglia; Ophthalmoscopy; Oxidative Stress; Poly(ADP-ribose) Polymerases; Rats; Retina; Streptozocin; Tyrosine | 2008 |
Cataract formation through the polyol pathway is associated with free radical production.
Topics: Aldehyde Reductase; Animals; Cataract; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Galactose; Hydroxyl Radical; Imidazoles; Imidazolidines; Male; Models, Biological; Polymers; Rats; Rats, Sprague-Dawley | 1999 |